Global Prothrombin Time Testing Market

Prothrombin Time Testing Comprehensive Study by Type (Instruments, Consumables, Systems), Application (Thrombin Time (TT), Activated Partial Thromboplastin Time (APTT), Prothrombin Time (PT), Partial Thromboplastin Time (PTT), Others), Technology (Mechanical Technology, Electrochemical Technology, Optical Technology, Others), End-User (Diagnostic Laboratories, Hospitals, Clinical Laboratories, Home Care Settings, Others) Players and Region - Global Market Outlook to 2030

Prothrombin Time Testing Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Prothrombin Time Testing
Prothrombin time (PT) is a blood test that is utilized to evaluate the time required to clot blood. This test is beneficial to detect and diagnose several bleeding and excessive clotting disorders and is also utilized to monitor the efficiency of numerous anticoagulants. Prothrombin time (PT) is a blood test that is used to assess the time required to clot blood. This test is useful to detect and diagnose various bleeding and excessive clotting disorder and monitor the efficacy of various anticoagulants. The major factors contributing to the Prothrombin time testing market's growth include the increasing prevalence of cardiovascular diseases in the geriatric population. Cardiovascular disease (CVD) and blood disorders are the leading cause of death in several countries.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


Owing to a rapidly rising geriatric population and rising demand for point of care testing is leading the global prothrombin time testing market on a higher trajectory. The upward sloping curve, charted by a significant CAGR (Compound Annual Growth Rate) will lead to a notable increase in market worth. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Prothrombin Time Testing market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Sysmex Corporation (Japan), Medtronic (Ireland), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (United States), Micropoint Biosciences (China), ARKRAY, Inc (Japan), NIHON KOHDEN CORPORATION (Japan), Diagnostica Stago S.A.S. (France), Thermo Fisher Scientific (United States), Helena Laboratories (United States), Siemens Healthcare GmbH (Germany), SEKISUI MEDICAL CO., LTD (Japan), Coagulation Sciences LLC (United States), Universal Biosensors (Australia), HemoSonics, LLC (United States) and Beckman Coulter, Inc (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Prothrombin Time Testing market by Type (Instruments, Consumables and Systems), Application (Thrombin Time (TT), Activated Partial Thromboplastin Time (APTT), Prothrombin Time (PT), Partial Thromboplastin Time (PTT) and Others) and Region.



On the basis of geography, the market of Prothrombin Time Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Mechanical Technology will boost the Prothrombin Time Testing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-User, the sub-segment i.e. Diagnostic Laboratories will boost the Prothrombin Time Testing market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
The Increased Utilization of Point-Of-Care Testing (Poct) Products and High Efficiency of The Devices for Detecting the Blood Disorders

Market Growth Drivers:
The Growing of The Incidences of Cardiovascular Diseases and Increasing Of the Elderly Population

Challenges:
High Cost of The Testing and Lack Of Awareness

Restraints:
The Stringent Guidelines by Several Governing Authorities and The approval procedure has become time-consuming and complicated

Opportunities:
Increasing Research and Development Activities

In 2019, ARKRAY, Inc. launched SPOTCHEM HS HS-7710, a blood coagulation testing product. It is faster and more efficient than other variants and allows for analysis, using whole blood samples, in surgical sites. Besides, it is automated. This is innovative and one of a kind in terms of blood analysis in surgeries. This demonstrates how product development and thus, research and development hold a crucial place in the market. and In 2018, Hoffman-La Roche Ltd launched CoaguChek Vantus. It is a home care setting coagulation testing system that is wireless and facilitates self-tests for patients. Mainly, it measures blood thinners’ effectiveness and sends data for analysis to healthcare providers.


Key Target Audience
Providers of Prothrombin Time Testing, Governmental and Regulatory bodies and End-Users

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Instruments
  • Consumables
  • Systems
By Application
  • Thrombin Time (TT)
  • Activated Partial Thromboplastin Time (APTT)
  • Prothrombin Time (PT)
  • Partial Thromboplastin Time (PTT)
  • Others
By Technology
  • Mechanical Technology
  • Electrochemical Technology
  • Optical Technology
  • Others

By End-User
  • Diagnostic Laboratories
  • Hospitals
  • Clinical Laboratories
  • Home Care Settings
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Growing of The Incidences of Cardiovascular Diseases
      • 3.2.2. Increasing Of the Elderly Population
    • 3.3. Market Challenges
      • 3.3.1. High Cost of The Testing
      • 3.3.2. Lack Of Awareness
    • 3.4. Market Trends
      • 3.4.1. The Increased Utilization of Point-Of-Care Testing (Poct) Products
      • 3.4.2. High Efficiency of The Devices for Detecting the Blood Disorders
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Prothrombin Time Testing, by Type, Application, Technology, End-User and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Prothrombin Time Testing (Value)
      • 5.2.1. Global Prothrombin Time Testing by: Type (Value)
        • 5.2.1.1. Instruments
        • 5.2.1.2. Consumables
        • 5.2.1.3. Systems
      • 5.2.2. Global Prothrombin Time Testing by: Application (Value)
        • 5.2.2.1. Thrombin Time (TT)
        • 5.2.2.2. Activated Partial Thromboplastin Time (APTT)
        • 5.2.2.3. Prothrombin Time (PT)
        • 5.2.2.4. Partial Thromboplastin Time (PTT)
        • 5.2.2.5. Others
      • 5.2.3. Global Prothrombin Time Testing by: Technology (Value)
        • 5.2.3.1. Mechanical Technology
        • 5.2.3.2. Electrochemical Technology
        • 5.2.3.3. Optical Technology
        • 5.2.3.4. Others
      • 5.2.4. Global Prothrombin Time Testing by: End-User (Value)
        • 5.2.4.1. Diagnostic Laboratories
        • 5.2.4.2. Hospitals
        • 5.2.4.3. Clinical Laboratories
        • 5.2.4.4. Home Care Settings
        • 5.2.4.5. Others
      • 5.2.5. Global Prothrombin Time Testing Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Australia
          • 5.2.5.2.6. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Prothrombin Time Testing (Price)
      • 5.3.1. Global Prothrombin Time Testing by: Type (Price)
  • 6. Prothrombin Time Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Sysmex Corporation (Japan)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. F. Hoffmann-La Roche Ltd (Switzerland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Abbott (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Micropoint Biosciences (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. ARKRAY, Inc (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. NIHON KOHDEN CORPORATION (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Diagnostica Stago S.A.S. (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Thermo Fisher Scientific (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Helena Laboratories (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Siemens Healthcare GmbH (Germany)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. SEKISUI MEDICAL CO., LTD (Japan)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Coagulation Sciences LLC (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Universal Biosensors (Australia)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. HemoSonics, LLC (United States)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. Beckman Coulter, Inc (United States)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
  • 7. Global Prothrombin Time Testing Sale, by Type, Application, Technology, End-User and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Prothrombin Time Testing (Value)
      • 7.2.1. Global Prothrombin Time Testing by: Type (Value)
        • 7.2.1.1. Instruments
        • 7.2.1.2. Consumables
        • 7.2.1.3. Systems
      • 7.2.2. Global Prothrombin Time Testing by: Application (Value)
        • 7.2.2.1. Thrombin Time (TT)
        • 7.2.2.2. Activated Partial Thromboplastin Time (APTT)
        • 7.2.2.3. Prothrombin Time (PT)
        • 7.2.2.4. Partial Thromboplastin Time (PTT)
        • 7.2.2.5. Others
      • 7.2.3. Global Prothrombin Time Testing by: Technology (Value)
        • 7.2.3.1. Mechanical Technology
        • 7.2.3.2. Electrochemical Technology
        • 7.2.3.3. Optical Technology
        • 7.2.3.4. Others
      • 7.2.4. Global Prothrombin Time Testing by: End-User (Value)
        • 7.2.4.1. Diagnostic Laboratories
        • 7.2.4.2. Hospitals
        • 7.2.4.3. Clinical Laboratories
        • 7.2.4.4. Home Care Settings
        • 7.2.4.5. Others
      • 7.2.5. Global Prothrombin Time Testing Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Australia
          • 7.2.5.2.6. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Prothrombin Time Testing (Price)
      • 7.3.1. Global Prothrombin Time Testing by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Prothrombin Time Testing: by Type(USD Million)
  • Table 2. Prothrombin Time Testing Instruments , by Region USD Million (2018-2023)
  • Table 3. Prothrombin Time Testing Consumables , by Region USD Million (2018-2023)
  • Table 4. Prothrombin Time Testing Systems , by Region USD Million (2018-2023)
  • Table 5. Prothrombin Time Testing: by Application(USD Million)
  • Table 6. Prothrombin Time Testing Thrombin Time (TT) , by Region USD Million (2018-2023)
  • Table 7. Prothrombin Time Testing Activated Partial Thromboplastin Time (APTT) , by Region USD Million (2018-2023)
  • Table 8. Prothrombin Time Testing Prothrombin Time (PT) , by Region USD Million (2018-2023)
  • Table 9. Prothrombin Time Testing Partial Thromboplastin Time (PTT) , by Region USD Million (2018-2023)
  • Table 10. Prothrombin Time Testing Others , by Region USD Million (2018-2023)
  • Table 11. Prothrombin Time Testing: by Technology(USD Million)
  • Table 12. Prothrombin Time Testing Mechanical Technology , by Region USD Million (2018-2023)
  • Table 13. Prothrombin Time Testing Electrochemical Technology , by Region USD Million (2018-2023)
  • Table 14. Prothrombin Time Testing Optical Technology , by Region USD Million (2018-2023)
  • Table 15. Prothrombin Time Testing Others , by Region USD Million (2018-2023)
  • Table 16. Prothrombin Time Testing: by End-User(USD Million)
  • Table 17. Prothrombin Time Testing Diagnostic Laboratories , by Region USD Million (2018-2023)
  • Table 18. Prothrombin Time Testing Hospitals , by Region USD Million (2018-2023)
  • Table 19. Prothrombin Time Testing Clinical Laboratories , by Region USD Million (2018-2023)
  • Table 20. Prothrombin Time Testing Home Care Settings , by Region USD Million (2018-2023)
  • Table 21. Prothrombin Time Testing Others , by Region USD Million (2018-2023)
  • Table 22. South America Prothrombin Time Testing, by Country USD Million (2018-2023)
  • Table 23. South America Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 24. South America Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 25. South America Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 26. South America Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 27. Brazil Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 28. Brazil Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 29. Brazil Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 30. Brazil Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 31. Argentina Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 32. Argentina Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 33. Argentina Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 34. Argentina Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 35. Rest of South America Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 36. Rest of South America Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 37. Rest of South America Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 38. Rest of South America Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 39. Asia Pacific Prothrombin Time Testing, by Country USD Million (2018-2023)
  • Table 40. Asia Pacific Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 41. Asia Pacific Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 42. Asia Pacific Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 43. Asia Pacific Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 44. China Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 45. China Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 46. China Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 47. China Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 48. Japan Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 49. Japan Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 50. Japan Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 51. Japan Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 52. India Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 53. India Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 54. India Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 55. India Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 56. South Korea Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 57. South Korea Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 58. South Korea Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 59. South Korea Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 60. Australia Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 61. Australia Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 62. Australia Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 63. Australia Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 64. Rest of Asia-Pacific Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 65. Rest of Asia-Pacific Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 66. Rest of Asia-Pacific Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 67. Rest of Asia-Pacific Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 68. Europe Prothrombin Time Testing, by Country USD Million (2018-2023)
  • Table 69. Europe Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 70. Europe Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 71. Europe Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 72. Europe Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 73. Germany Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 74. Germany Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 75. Germany Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 76. Germany Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 77. France Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 78. France Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 79. France Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 80. France Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 81. Italy Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 82. Italy Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 83. Italy Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 84. Italy Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 85. United Kingdom Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 86. United Kingdom Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 87. United Kingdom Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 88. United Kingdom Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 89. Netherlands Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 90. Netherlands Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 91. Netherlands Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 92. Netherlands Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 93. Rest of Europe Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 94. Rest of Europe Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 95. Rest of Europe Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 96. Rest of Europe Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 97. MEA Prothrombin Time Testing, by Country USD Million (2018-2023)
  • Table 98. MEA Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 99. MEA Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 100. MEA Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 101. MEA Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 102. Middle East Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 103. Middle East Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 104. Middle East Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 105. Middle East Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 106. Africa Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 107. Africa Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 108. Africa Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 109. Africa Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 110. North America Prothrombin Time Testing, by Country USD Million (2018-2023)
  • Table 111. North America Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 112. North America Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 113. North America Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 114. North America Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 115. United States Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 116. United States Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 117. United States Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 118. United States Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 119. Canada Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 120. Canada Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 121. Canada Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 122. Canada Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 123. Mexico Prothrombin Time Testing, by Type USD Million (2018-2023)
  • Table 124. Mexico Prothrombin Time Testing, by Application USD Million (2018-2023)
  • Table 125. Mexico Prothrombin Time Testing, by Technology USD Million (2018-2023)
  • Table 126. Mexico Prothrombin Time Testing, by End-User USD Million (2018-2023)
  • Table 127. Prothrombin Time Testing: by Type(USD/Units)
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Prothrombin Time Testing: by Type(USD Million)
  • Table 145. Prothrombin Time Testing Instruments , by Region USD Million (2025-2030)
  • Table 146. Prothrombin Time Testing Consumables , by Region USD Million (2025-2030)
  • Table 147. Prothrombin Time Testing Systems , by Region USD Million (2025-2030)
  • Table 148. Prothrombin Time Testing: by Application(USD Million)
  • Table 149. Prothrombin Time Testing Thrombin Time (TT) , by Region USD Million (2025-2030)
  • Table 150. Prothrombin Time Testing Activated Partial Thromboplastin Time (APTT) , by Region USD Million (2025-2030)
  • Table 151. Prothrombin Time Testing Prothrombin Time (PT) , by Region USD Million (2025-2030)
  • Table 152. Prothrombin Time Testing Partial Thromboplastin Time (PTT) , by Region USD Million (2025-2030)
  • Table 153. Prothrombin Time Testing Others , by Region USD Million (2025-2030)
  • Table 154. Prothrombin Time Testing: by Technology(USD Million)
  • Table 155. Prothrombin Time Testing Mechanical Technology , by Region USD Million (2025-2030)
  • Table 156. Prothrombin Time Testing Electrochemical Technology , by Region USD Million (2025-2030)
  • Table 157. Prothrombin Time Testing Optical Technology , by Region USD Million (2025-2030)
  • Table 158. Prothrombin Time Testing Others , by Region USD Million (2025-2030)
  • Table 159. Prothrombin Time Testing: by End-User(USD Million)
  • Table 160. Prothrombin Time Testing Diagnostic Laboratories , by Region USD Million (2025-2030)
  • Table 161. Prothrombin Time Testing Hospitals , by Region USD Million (2025-2030)
  • Table 162. Prothrombin Time Testing Clinical Laboratories , by Region USD Million (2025-2030)
  • Table 163. Prothrombin Time Testing Home Care Settings , by Region USD Million (2025-2030)
  • Table 164. Prothrombin Time Testing Others , by Region USD Million (2025-2030)
  • Table 165. South America Prothrombin Time Testing, by Country USD Million (2025-2030)
  • Table 166. South America Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 167. South America Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 168. South America Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 169. South America Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 170. Brazil Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 171. Brazil Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 172. Brazil Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 173. Brazil Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 174. Argentina Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 175. Argentina Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 176. Argentina Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 177. Argentina Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 178. Rest of South America Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 179. Rest of South America Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 180. Rest of South America Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 181. Rest of South America Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 182. Asia Pacific Prothrombin Time Testing, by Country USD Million (2025-2030)
  • Table 183. Asia Pacific Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 184. Asia Pacific Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 185. Asia Pacific Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 186. Asia Pacific Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 187. China Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 188. China Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 189. China Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 190. China Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 191. Japan Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 192. Japan Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 193. Japan Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 194. Japan Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 195. India Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 196. India Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 197. India Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 198. India Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 199. South Korea Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 200. South Korea Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 201. South Korea Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 202. South Korea Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 203. Australia Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 204. Australia Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 205. Australia Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 206. Australia Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 207. Rest of Asia-Pacific Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 208. Rest of Asia-Pacific Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 209. Rest of Asia-Pacific Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 210. Rest of Asia-Pacific Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 211. Europe Prothrombin Time Testing, by Country USD Million (2025-2030)
  • Table 212. Europe Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 213. Europe Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 214. Europe Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 215. Europe Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 216. Germany Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 217. Germany Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 218. Germany Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 219. Germany Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 220. France Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 221. France Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 222. France Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 223. France Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 224. Italy Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 225. Italy Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 226. Italy Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 227. Italy Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 228. United Kingdom Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 229. United Kingdom Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 230. United Kingdom Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 231. United Kingdom Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 232. Netherlands Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 233. Netherlands Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 234. Netherlands Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 235. Netherlands Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 236. Rest of Europe Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 237. Rest of Europe Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 238. Rest of Europe Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 239. Rest of Europe Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 240. MEA Prothrombin Time Testing, by Country USD Million (2025-2030)
  • Table 241. MEA Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 242. MEA Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 243. MEA Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 244. MEA Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 245. Middle East Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 246. Middle East Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 247. Middle East Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 248. Middle East Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 249. Africa Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 250. Africa Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 251. Africa Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 252. Africa Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 253. North America Prothrombin Time Testing, by Country USD Million (2025-2030)
  • Table 254. North America Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 255. North America Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 256. North America Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 257. North America Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 258. United States Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 259. United States Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 260. United States Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 261. United States Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 262. Canada Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 263. Canada Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 264. Canada Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 265. Canada Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 266. Mexico Prothrombin Time Testing, by Type USD Million (2025-2030)
  • Table 267. Mexico Prothrombin Time Testing, by Application USD Million (2025-2030)
  • Table 268. Mexico Prothrombin Time Testing, by Technology USD Million (2025-2030)
  • Table 269. Mexico Prothrombin Time Testing, by End-User USD Million (2025-2030)
  • Table 270. Prothrombin Time Testing: by Type(USD/Units)
  • Table 271. Research Programs/Design for This Report
  • Table 272. Key Data Information from Secondary Sources
  • Table 273. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Prothrombin Time Testing: by Type USD Million (2018-2023)
  • Figure 5. Global Prothrombin Time Testing: by Application USD Million (2018-2023)
  • Figure 6. Global Prothrombin Time Testing: by Technology USD Million (2018-2023)
  • Figure 7. Global Prothrombin Time Testing: by End-User USD Million (2018-2023)
  • Figure 8. South America Prothrombin Time Testing Share (%), by Country
  • Figure 9. Asia Pacific Prothrombin Time Testing Share (%), by Country
  • Figure 10. Europe Prothrombin Time Testing Share (%), by Country
  • Figure 11. MEA Prothrombin Time Testing Share (%), by Country
  • Figure 12. North America Prothrombin Time Testing Share (%), by Country
  • Figure 13. Global Prothrombin Time Testing: by Type USD/Units (2018-2023)
  • Figure 14. Global Prothrombin Time Testing share by Players 2023 (%)
  • Figure 15. Global Prothrombin Time Testing share by Players (Top 3) 2023(%)
  • Figure 16. Global Prothrombin Time Testing share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Sysmex Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 19. Sysmex Corporation (Japan) Revenue: by Geography 2023
  • Figure 20. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 21. Medtronic (Ireland) Revenue: by Geography 2023
  • Figure 22. F. Hoffmann-La Roche Ltd (Switzerland) Revenue, Net Income and Gross profit
  • Figure 23. F. Hoffmann-La Roche Ltd (Switzerland) Revenue: by Geography 2023
  • Figure 24. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 25. Abbott (United States) Revenue: by Geography 2023
  • Figure 26. Micropoint Biosciences (China) Revenue, Net Income and Gross profit
  • Figure 27. Micropoint Biosciences (China) Revenue: by Geography 2023
  • Figure 28. ARKRAY, Inc (Japan) Revenue, Net Income and Gross profit
  • Figure 29. ARKRAY, Inc (Japan) Revenue: by Geography 2023
  • Figure 30. NIHON KOHDEN CORPORATION (Japan) Revenue, Net Income and Gross profit
  • Figure 31. NIHON KOHDEN CORPORATION (Japan) Revenue: by Geography 2023
  • Figure 32. Diagnostica Stago S.A.S. (France) Revenue, Net Income and Gross profit
  • Figure 33. Diagnostica Stago S.A.S. (France) Revenue: by Geography 2023
  • Figure 34. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 35. Thermo Fisher Scientific (United States) Revenue: by Geography 2023
  • Figure 36. Helena Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 37. Helena Laboratories (United States) Revenue: by Geography 2023
  • Figure 38. Siemens Healthcare GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 39. Siemens Healthcare GmbH (Germany) Revenue: by Geography 2023
  • Figure 40. SEKISUI MEDICAL CO., LTD (Japan) Revenue, Net Income and Gross profit
  • Figure 41. SEKISUI MEDICAL CO., LTD (Japan) Revenue: by Geography 2023
  • Figure 42. Coagulation Sciences LLC (United States) Revenue, Net Income and Gross profit
  • Figure 43. Coagulation Sciences LLC (United States) Revenue: by Geography 2023
  • Figure 44. Universal Biosensors (Australia) Revenue, Net Income and Gross profit
  • Figure 45. Universal Biosensors (Australia) Revenue: by Geography 2023
  • Figure 46. HemoSonics, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 47. HemoSonics, LLC (United States) Revenue: by Geography 2023
  • Figure 48. Beckman Coulter, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 49. Beckman Coulter, Inc (United States) Revenue: by Geography 2023
  • Figure 50. Global Prothrombin Time Testing: by Type USD Million (2025-2030)
  • Figure 51. Global Prothrombin Time Testing: by Application USD Million (2025-2030)
  • Figure 52. Global Prothrombin Time Testing: by Technology USD Million (2025-2030)
  • Figure 53. Global Prothrombin Time Testing: by End-User USD Million (2025-2030)
  • Figure 54. South America Prothrombin Time Testing Share (%), by Country
  • Figure 55. Asia Pacific Prothrombin Time Testing Share (%), by Country
  • Figure 56. Europe Prothrombin Time Testing Share (%), by Country
  • Figure 57. MEA Prothrombin Time Testing Share (%), by Country
  • Figure 58. North America Prothrombin Time Testing Share (%), by Country
  • Figure 59. Global Prothrombin Time Testing: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Sysmex Corporation (Japan)
  • Medtronic (Ireland)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Abbott (United States)
  • Micropoint Biosciences (China)
  • ARKRAY, Inc (Japan)
  • NIHON KOHDEN CORPORATION (Japan)
  • Diagnostica Stago S.A.S. (France)
  • Thermo Fisher Scientific (United States)
  • Helena Laboratories (United States)
  • Siemens Healthcare GmbH (Germany)
  • SEKISUI MEDICAL CO., LTD (Japan)
  • Coagulation Sciences LLC (United States)
  • Universal Biosensors (Australia)
  • HemoSonics, LLC (United States)
  • Beckman Coulter, Inc (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 148 Pages 90 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Prothrombin Time Testing Market Quantitative research analysis
Global Prothrombin Time Testing Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Sysmex Corporation (Japan), Medtronic (Ireland), F. Hoffmann-La Roche Ltd (Switzerland), Abbott (United States), Micropoint Biosciences (China), ARKRAY, Inc (Japan), NIHON KOHDEN CORPORATION (Japan), Diagnostica Stago S.A.S. (France), Thermo Fisher Scientific (United States), Helena Laboratories (United States), Siemens Healthcare GmbH (Germany), SEKISUI MEDICAL CO., LTD (Japan), Coagulation Sciences LLC (United States), Universal Biosensors (Australia), HemoSonics, LLC (United States) and Beckman Coulter, Inc (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"The Increased Utilization of Point-Of-Care Testing (Poct) Products " is seen as one of major influencing trends for Prothrombin Time Testing Market during projected period 2023-2030.
The Prothrombin Time Testing market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Prothrombin Time Testing Market Report?

Have a Query? Click Here

Other Related Reports

At-Home Fitness Equipment Comprehensive Study by Type (Treadmills, Elliptical Machines, Stationary Cycles, Rowing Machines, Strength Training Equipment, Others), Price Range (Low, Medium, High), Dist...
$ 3650
Fall Management Comprehensive Study by Type (Sensor Pad, Floor Mat, RFID Tag), Application (Hospitals and Clinics, Nursing Home, Others) Players and Region - Global Market Outlook to 2030
$ 3500
Stress/Anxiety Treatment for Dogs & Cats Comprehensive Study by Sales Channel (Offline (Vets, Retail), Online), Medication (Product Category, - Drug (Diazepam, Sileo, Clomicalm, fluoxetine, Paroxetin...
$ 3750
Flect Ct Imaging Comprehensive Study by Application (Oncology, Immunology, Cell Trafficking - NirFP, Drug Delivery, Cardiovascular Research, Neuroscience, Others), End Users (Clinical Research labora...
$ 3650
Pet Eye Cleaners Comprehensive Study by Type (Liquid Drops, Location, Eye Wipes, Eye Gel), Animals (Dogs, Cat, Birds, Other), Infection (Allergies, Birth defects, Tear duct issues, Injuries, Dry eye...
$ 3750
Medical Supply Delivery Service Comprehensive Study by Application (Medical Supply Delivery, Hospital Delivery, Specimen Transportation, Radioactive Materials, Surgical Deliveries, Others), Platforms...
$ 3650